MELBOURNE, AUSTRALIA--(Marketwire - March 14, 2008) - Prana Biotechnology Limited (NASDAQ: PRAN) (ASX: PBT) today announced that the Company has posted a new investor presentation which includes further details regarding the results of PBT2's Phase IIa clinical trial, on the Company's website.
